All posts by: Michael Zand

About Michael Zand

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula – EurekAlert (press release)

Continue reading

2017-09-14 NEWS

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
EurekAlert (press release)
14, 2017–A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery.
Mesenchymal Stem Cells Market Regulations and Competitive Landscape Outlook to 2025Digital Journal

all 2 news articles »

Continue reading

2017-09-14 NEWS

Mesenchymal stem cells offer novel treatment approach for Crohn’s disease fistula
EurekAlert (press release)
14, 2017–A growing body of clinical evidence shows that transplantation of a patient’s own mesenchymal stem cells (MSCs) to achieve a cure and prevent recurrent of Crohn’s disease-related fistula can be a safe and effective addition to surgery.
Mesenchymal Stem Cells Market Regulations and Competitive Landscape Outlook to 2025Digital Journal

all 2 news articles »

Continue reading

2017-09-14 NEWS

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures
GenomeWeb
NEW YORK (GenomeWeb) – Using two relatively new technologies — CRISPR-Cas9 genome editing and organoid culture techniques — researchers in the Netherlands and the UK have identified a specific DNA repair defect as the underlying cause of a …

Continue reading

2017-09-14 NEWS

Researchers Track Cancer Mutations Using CRISPR, Organoid Cultures
GenomeWeb
NEW YORK (GenomeWeb) – Using two relatively new technologies — CRISPR-Cas9 genome editing and organoid culture techniques — researchers in the Netherlands and the UK have identified a specific DNA repair defect as the underlying cause of a …

Continue reading

2017-09-14 NEWS

Novartis and the Future of Gene Therapy
GuruFocus.com
Gene therapy is now, finally, a new weapon in our arsenal against cancer partly thanks to, of all things, the HIV virus. The world’s first chimeric antigen receptor T-cell (CAR-T) treatment was approved by the Food and Drug Administration at the end of

and more »